Stock Chart
KRYS
Type: SELL growth_1yr
Strike: $400
Premium: $38.00
Expiry: Jun 17, 2027
Target: $373
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About KRYS - Krystal Biotech, Inc. Common Stock
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in …
Key Statistics
More KRYS Analysis
This KRYS stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track KRYS's price movements with trendlines, gamma walls, and key support/resistance levels.